Biomarin Pharmaceutical Inc. Stock Performance
as on September 19, 2025 at 1:29 am IST
Day's Low
Day's High
$54.43$55.21
1.31%
Downside
0.11%
Upside
52 Week's Low
52 Week's High
$52.93$73.514.03%
Downside
33.29%
Upside
Biomarin Pharmaceutical Inc. share price movements today
- Previous Close
- $54.37
- Open
- $54.77
- Volume
- 1.1M
- Day's Low - High
- $54.43 - $55.21
- 52 Week Low - High
- $52.93 - $73.51
Biomarin Pharmaceutical Inc. Historical Returns
- 1 Month Return
- -5.34 %
- 3 Month Return
- -1.57 %
- 1 Year Return
- -23.57 %
- 3 Year Return
- -38.36 %
- 5 Year Return
- -31.51 %
Biomarin Pharmaceutical Inc. Stock Fundamentals & Key Indicators
Check Biomarin Pharmaceutical Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$10.4B
EPS (TTM)
4.3268
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
1.24%
PE Ratio (TTM)
16.04
Industry PE ratio
16.65525641025641
P/B Ratio
16.0383
PEG Ratio
0.6149
EBITDA
955.2M
Revenue (TTM)
3.1B
Profit Margin
21.45%
Return On Equity TTM
11.62%
Biomarin Pharmaceutical Inc. Stock Valuation
Track how Biomarin Pharmaceutical Inc. P/E has moved over time to understand its valuation trends.
Biomarin Pharmaceutical Inc. in the last 5 years
Lowest (14.58x)
June 30, 2025
Today (16.04x)
September 18, 2025
Industry (16.66x)
September 18, 2025
Highest (181.43x)
June 30, 2023
Today’s Price to Earnings Ratio: 16.04x
Biomarin Pharmaceutical Inc. vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Biomarin Pharmaceutical Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $10.4B | -31.51% | 16.04 | 21.45% | |
| BUY | $60.5B | 241.54% | -505.15 | -12.96% | |
| NA | $38.7B | NA | NA | -3.89% | |
| BUY | $99.3B | 45.88% | 27.56 | 31.86% | |
| BUY | $60.9B | 5.45% | 14.49 | 31.37% |
Stock Returns calculator for Biomarin Pharmaceutical Inc. Stock including INR - Dollar returns
The Biomarin Pharmaceutical Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Biomarin Pharmaceutical Inc. investment value today
Current value as on today
₹82,476
Returns
Returns from Biomarin Pharmaceutical Inc. Stock
Dollar Returns*
₹4,953 (+4.95%)
Analyst Recommendation on Biomarin Pharmaceutical Inc. Stock
Based on 35 analysts
74.29%
Buy
25.71%
Hold
0.00%
Sell
Based on 35 analysts, 74.29% of analysts recommend a 'BUY' rating for Biomarin Pharmaceutical Inc.. Average target price of $96.59
Biomarin Pharmaceutical Inc. Share Price Target
Get share price movements and forecasts by analysts on Biomarin Pharmaceutical Inc..
What analysts predicted
42.9%UPSIDE
Target Price
$96.59
Current Price
$55.15
Analyzed by
35 Analysts
Target
$96.59
Biomarin Pharmaceutical Inc. target price $96.59, a slight upside of 42.9% compared to current price of $55.15. According to 35 analysts rating.
Biomarin Pharmaceutical Inc. Stock's Interest Amongst Investors
Search interest for Biomarin Pharmaceutical Inc. Stock has decreased by -33% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Biomarin Pharmaceutical Inc. Quarterly Profit & Loss
All numbers in Millions USD
Biomarin Pharmaceutical Inc. Annual Profit & Loss
All numbers in Millions USD
Biomarin Pharmaceutical Inc. Quarterly Cash Flow
All numbers in Millions USD
Biomarin Pharmaceutical Inc. Annual Cash Flow
All numbers in Millions USD
Biomarin Pharmaceutical Inc. News & Key Events
Today's Timeline - 16 September
Tue, 07:21 PM
-BioMarin presents new VOXZOGO efficacy data at ASBMR Annual Meeting, highlighting anatomical improvements in children.
Tue, 10:07 PM
-BioMarin reports Q2 2025 revenues of $813 million, up 16% year-over-year, driven by U.S. growth and international expansion.
Insights on Biomarin Pharmaceutical Inc.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTProfit Spike
Netprofit is up for the last 4 quarters, 106.08M → 240.53M (in $), with an average increase of 23.5% per quarter
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 745.14M → 825.41M (in $), with an average increase of 9.7% per quarter
NO EFFECTAgainst Peers
In the last 1 year, Beone Medicines Ltd has given 68.4% return, outperforming this stock by 92.0%
- NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 111.5% return, outperforming this stock by 149.9%
NEGATIVE IMPACTPrice Dip
In the last 1 month, BMRN stock has moved down by -5.3%
About Biomarin Pharmaceutical Inc.
| Organisation | Biomarin Pharmaceutical Inc. |
| Headquarters | 770 Lindaro Street, San Rafael, CA, United States, 94901 |
| Industry | Health Technology |
| CEO | Mr. Alexander Hardy |
| E-voting on shares | Click here to vote |
Key Management of Biomarin Pharmaceutical Inc.
Name | Title |
|---|---|
Dr. Ganesh Vedantham Ph.D. | Senior Vice President of Technical Development |
Ms. Marni Kottle | Executive VP & Chief Corporate Affairs Officer |
Ms. Cristin Hubbard | Executive VP & Chief Commercial Officer |
Dr. Kevin Eggan Ph.D. | Chief Scientific Officer & Senior VP of Research and Early Development |
Mr. George Eric Davis J.D. | Executive VP, Chief Legal Officer, General Counsel & Secretary |
Dr. Gregory Friberg M.D. | Executive VP and Chief Research & Development Officer |
Dr. C. Greg Guyer Ph.D. | Executive VP & CTO |
Ms. Amy Wireman | Executive VP & Chief People Officer |
Mr. Alexander Hardy | President, CEO & Director |
Mr. Brian R. Mueller CPA | Executive VP of Finance, CFO & Principal Accounting Officer |
FAQs
What is Biomarin Pharmaceutical Inc. share price today?
Biomarin Pharmaceutical Inc. share price today is $55.15 as on at the close of the market. Biomarin Pharmaceutical Inc. share today touched a day high of $55.21 and a low of $54.43.
What is the 52 week high and 52 week low for Biomarin Pharmaceutical Inc. share?
Biomarin Pharmaceutical Inc. share touched a 52 week high of $73.51 on and a 52 week low of $52.93 on . Biomarin Pharmaceutical Inc. stock price today i.e. is closed at $55.15,which is 24.98% down from its 52 week high and 4.19% up from its 52 week low.
What is Biomarin Pharmaceutical Inc.'s market capitalisation today?
Biomarin Pharmaceutical Inc. market capitalisation is $0.01T as on .
How to invest in Biomarin Pharmaceutical Inc. Stock (BMRN) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Biomarin Pharmaceutical Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Biomarin Pharmaceutical Inc. Shares that will get you 0.0272 shares as per Biomarin Pharmaceutical Inc. share price of $55.15 per share as on September 19, 2025 at 1:29 am IST.
What is the minimum amount required to buy Biomarin Pharmaceutical Inc. Stock (BMRN) from India?
Indian investors can start investing in Biomarin Pharmaceutical Inc. (BMRN) shares with as little as ₹88.114 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.14 in Biomarin Pharmaceutical Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Biomarin Pharmaceutical Inc. share’s latest price of $55.15 as on September 19, 2025 at 1:29 am IST, you will get 0.1813 shares of Biomarin Pharmaceutical Inc.. Learn more about
fractional shares .
What are the returns that Biomarin Pharmaceutical Inc. has given to Indian investors in the last 5 years?
Biomarin Pharmaceutical Inc. stock has given -31.51% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?